| NCT Number | NCT07527585 |
| Lead Sponsor | Huazhong University of Science and Technology |
| Conditions | Immune-Related Adverse Events |
| Enrollment | 440 participants |
| Start Date | 2026-04 |
| Primary Completion | 2032-12 (estimated) |
| Study Completion | 2032-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-14 |